Oricula Therapeutics
Manufacturing · Washington, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
474 39th Ave E, Seattle, Washington, 981...Phone Number
(206) 322-7526Website
www.oricularx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Oricula Therapeutics
Oricula Therapeutics, LLC is focused on developing the first medication to prevent drug-induced hearing loss, specifically targeting the side effects of aminoglycoside antibiotics. Their lead product, ORC-13661, aims to preserve hearing during antibiotic treatment, which is crucial for managing life-threatening bacterial infections. The company has successfully completed Phase 1 human testing and is preparing for a Phase 2 clinical trial to demonstrate efficacy. Oricula Therapeutics is dedicated to protecting inner ear hair cells from damage caused by drugs and aging.Explore more
Oricula Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oricula Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Oricula Therapeutics launches new products
Earning: See what the market has to say on Oricula Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Oricula Therapeutics
Click to see if Oricula Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Oricula Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Oricula Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Oricula Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Oricula Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Oricula Therapeutics
Compare insights from companies similar to Oricula Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oricula Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Oricula Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oricula Therapeutics.
Oricula Therapeutics financials insights
Gather financial insights about Oricula Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Grant
$2.1M
Oricula Therapeutics Tech Stack
A closer look at the technologies used by Oricula Therapeutics
Oricula Therapeutics News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oricula Therapeutics
Sign Up For FreeTo access detailed company insights
Oricula Therapeutics, LLC is focused on developing the first medication to prevent drug-induced hearing loss, specifically targeting the side effects of aminoglycoside antibiotics. Their lead product, ORC-13661, aims to preserve hearing during antibiotic treatment, which is crucial for managing life-threatening bacterial infections. The company has... Read More
